PPD brings extensive experience in the nuances of post-approval studies, combined with a solid foundation in late-stage clinical trials management.
Experience across a broad range of indications and an investigator network of more than 6,000 cardiologists.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
Get information about PPD posted on industry websites and publications.
Workshop on Recent Issues in Bioanalysis (WRIB) is a large international conference attended by hundreds of people from pharmaceutical companies, biotechnology companies and contract research organizations. Bruce Stouffer, executive director of PPD® Laboratories bioanalytical lab, weighs in on his recent experiences at WRIB.
Chris Komelasky, a senior director of sites and patients, Rare Disease and Pediatric Center of Excellence, answers questions about his experiences at the World Orphan Drug Congress held in April.
Volker Hack, senior director and head of the project management standards group, and Denise Sackner, director of early development services standards, contribute their thoughts about three essentials for project management.
Philip Bartle, an associate director in clinical innovation, discusses the use of industry data standards, which can greatly drive efficiencies and reduce variations in data.
Steve Zdravkovic, a research scientist in the PPD® Laboratories GMP lab, writes about solid phase extraction (SPE) as an underutilized methodology.
We want to hear from you
Register in PPD's Database
© 2017 Pharmaceutical Product Development, LLC. All rights reserved.